KR20100093037A - 폐질환의 건강 관련 삶의 질 부족을 치료하기 위한 흡입용 아즈트레오남 라이신 - Google Patents

폐질환의 건강 관련 삶의 질 부족을 치료하기 위한 흡입용 아즈트레오남 라이신 Download PDF

Info

Publication number
KR20100093037A
KR20100093037A KR1020107009839A KR20107009839A KR20100093037A KR 20100093037 A KR20100093037 A KR 20100093037A KR 1020107009839 A KR1020107009839 A KR 1020107009839A KR 20107009839 A KR20107009839 A KR 20107009839A KR 20100093037 A KR20100093037 A KR 20100093037A
Authority
KR
South Korea
Prior art keywords
azli
aerosol
day
dose
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020107009839A
Other languages
English (en)
Korean (ko)
Inventor
알란 몽고메리
멜리사 예거
Original Assignee
길리애드 사이언시즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 길리애드 사이언시즈, 인코포레이티드 filed Critical 길리애드 사이언시즈, 인코포레이티드
Publication of KR20100093037A publication Critical patent/KR20100093037A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020107009839A 2007-10-01 2008-09-15 폐질환의 건강 관련 삶의 질 부족을 치료하기 위한 흡입용 아즈트레오남 라이신 Withdrawn KR20100093037A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US99707207P 2007-10-01 2007-10-01
US99707107P 2007-10-01 2007-10-01
US60/997,072 2007-10-01
US60/997,071 2007-10-01

Publications (1)

Publication Number Publication Date
KR20100093037A true KR20100093037A (ko) 2010-08-24

Family

ID=40032482

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107009839A Withdrawn KR20100093037A (ko) 2007-10-01 2008-09-15 폐질환의 건강 관련 삶의 질 부족을 치료하기 위한 흡입용 아즈트레오남 라이신

Country Status (15)

Country Link
US (1) US7973029B2 (enExample)
EP (1) EP2200608A1 (enExample)
JP (1) JP2010540539A (enExample)
KR (1) KR20100093037A (enExample)
CN (1) CN101951906A (enExample)
AR (1) AR068514A1 (enExample)
AU (1) AU2008307268A1 (enExample)
BR (1) BRPI0817636A2 (enExample)
CA (1) CA2701118A1 (enExample)
EA (1) EA201070336A1 (enExample)
IL (1) IL204593A0 (enExample)
MX (1) MX2010003618A (enExample)
NZ (1) NZ584269A (enExample)
TW (1) TW200927193A (enExample)
WO (1) WO2009045706A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60144291D1 (de) 2000-12-27 2011-05-05 Gilead Sciences Inc Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen
US7214364B2 (en) 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
CN104784159A (zh) * 2015-04-15 2015-07-22 苏州惠仁生物科技有限公司 氨曲南粉雾剂的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152456A (en) * 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
EP0615470B1 (en) * 1991-12-04 1995-12-13 The Technology Partnership Public Limited Company Fluid droplet production apparatus and method
US6962151B1 (en) * 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
DE19953317C1 (de) 1999-11-05 2001-02-01 Pari Gmbh Inhalationsvernebler
DE60144291D1 (de) * 2000-12-27 2011-05-05 Gilead Sciences Inc Inhalierbares aztreonam zur behandlung und vorbeugung von bakteriellen lungeninfektionen
US7138419B2 (en) * 2000-12-27 2006-11-21 Corus Pharma, Inc. Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
US7214364B2 (en) * 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
DE10102846B4 (de) * 2001-01-23 2012-04-12 Pari Pharma Gmbh Aerosolgenerator

Also Published As

Publication number Publication date
AU2008307268A1 (en) 2009-04-09
WO2009045706A1 (en) 2009-04-09
AR068514A1 (es) 2009-11-18
CA2701118A1 (en) 2009-04-09
IL204593A0 (en) 2010-11-30
EA201070336A1 (ru) 2011-06-30
CN101951906A (zh) 2011-01-19
NZ584269A (en) 2012-06-29
EP2200608A1 (en) 2010-06-30
TW200927193A (en) 2009-07-01
JP2010540539A (ja) 2010-12-24
US7973029B2 (en) 2011-07-05
BRPI0817636A2 (pt) 2019-09-24
MX2010003618A (es) 2010-04-21
US20090124594A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
US5508269A (en) Aminoglycoside formulation for aerosolization
JP2012107047A (ja) 気管支感染症の治療法
VanDevanter et al. Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review
Ashoor et al. Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial
IL164078A (en) Antithrombin iii for use in treating lung injury
KR20100093037A (ko) 폐질환의 건강 관련 삶의 질 부족을 치료하기 위한 흡입용 아즈트레오남 라이신
EP3393517B1 (en) Acetylsalicylic acid for use in the treatment of moderate to severe influenza
JP2010540539A5 (enExample)
TW201016215A (en) Compositions and uses of antiviral active pharmaceutical agents
Witt et al. Dornase alfa: a new option in the management of cystic fibrosis
Art et al. Pulmonary function and antimicrobial concentration after marbofloxacin inhalation in horses
US20230248722A1 (en) Clofazimine composition and method for the treatment or prophylaxis of viral infections
WO2022093767A1 (en) Alpha-2 adrenergic receptor agonists to reduce mortality and improve outcomes in viral respiratory syndromes
US20240342239A1 (en) Treatment of non-cystic fibrosis bronchiectasis
US20230113110A1 (en) Composition for the treatment of lesions of the respiratory system
US12178841B2 (en) Treatment of non-cystic fibrosis bronchiectasis
CN114129705B (zh) 一种多肽在预防和治疗肺炎的药物中的应用
KR20240033039A (ko) 호흡기 질환의 치료
US20230310467A1 (en) PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + REMDESIVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19
Ibrahim et al. Inhaled Therapy for Other Respiratory Diseases: Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis
CN117442588A (zh) 一种吸入用人干扰素α2b溶液及其制备方法
Alfano et al. Le Infezioni in Medicina, n. 1, 11-21, 2022
JPWO2006078066A1 (ja) 経気道呼吸器感染症治療剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100503

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid